InvestorsHub Logo
Followers 84
Posts 32217
Boards Moderated 85
Alias Born 03/22/2005

Re: None

Thursday, 12/12/2019 7:26:35 AM

Thursday, December 12, 2019 7:26:35 AM

Post# of 1643
>>> Magic Mushrooms Pass First Hurdle as Depression Treatment


Bloomberg

By Marthe Fourcade

December 12, 2019


https://www.bloomberg.com/news/articles/2019-12-12/magic-mushrooms-pass-first-hurdle-as-depression-treatment


Another party drug is showing signs of going legit as magic mushrooms cleared the first hurdle of tests required to become a treatment for depression.

The active ingredient in the mushrooms, psilocybin, was found to be safe and well tolerated when given to healthy volunteers in a study by researchers at King’s College London. Unsurprisingly, the subjects got high.

Companies and researchers have been investigating the medical and commercial potential of recreational drugs like marijuana. Closely held Compass Pathways is working to bring to market a version of psilocybin for depression that resists other treatments. The company sponsored the trial, which according to organizers was the largest controlled study of the chemical to date.

“Changes in sensory perception and positive mood alteration” were among the most frequent reactions doctors noted in the trial, Compass said in a statement.

Psilocybin is drawing researchers’ attention as a potential treatment for more than just depression. Scientists are seeking to enlist patients to test the chemical for ailments including Alzheimer’s disease, anorexia, obsessive-compulsive disorder and migraines.

<<<




Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.